Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05631327
Title JZP341 Phase 1 Dose-Finding Study in Adult Participants With Advanced or Metastatic Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Jazz Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
SCRI HealthOne Denver Colorado 80218 United States Details
Florida Cancer Specialists - Sarasota Sarasota Florida 34232 United States Details
University of Maryland Medical Center Baltimore Maryland 21201 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901 United States Details
Oklahoma University- Oklahoma City Oklahoma City Oklahoma 73106 United States Details
Thomas Jefferson University/Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
Tennessee Oncology - Nashville Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field